Catalio Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.9M Buy
6,168,749
+676,883
+12% +$482K 0.92% 30
2026
Q1
$2.51M Hold
5,491,866
0.53% 36
2025
Q4
$12.1M Buy
5,491,866
+277,630
+5% +$447K 2.14% 20
2025
Q3
$8.29M Buy
5,214,236
+5,000,000
+2,334% +$6.49M 1.53% 24
2025
Q2
$347K Hold
214,236
0.07% 39
2025
Q1
$255K Hold
214,236
0.06% 36
2024
Q4
$441K Buy
+214,236
New +$499K 0.1% 31

Other funds holding GUTS

Catalio Capital Management's GUTS Position: Q2 2026 in Review

Catalio Capital Management increased its Fractyl Health (GUTS) stake by 12% in Q2 2026, buying an estimated $482K and bringing the position to 6,168,749 shares worth $4.9M. The position accounts for 0.92% of the portfolio, ranked #30.

Catalio Capital Management first reported a position in GUTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.1M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Catalio Capital Management held 6,168,749 shares of Fractyl Health worth $4.9M as of Q2 2026.
  • Catalio Capital Management bought 676,883 Fractyl Health shares in Q2 2026, an estimated $482K.
  • Fractyl Health made up 0.92% of Catalio Capital Management's portfolio in Q2 2026, its #30 holding.
  • Catalio Capital Management first reported a position in Fractyl Health in Q4 2024 and has held it in 7 quarters since.
  • Catalio Capital Management's Fractyl Health position peaked at $12.1M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Catalio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.